William Y Kim

16PUBLICATIONS
75CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 04, 2026
Immunodominance Hierarchy of Endogenous BBN963 Bladder Cancer Antigens Remains Stable Under Anti-PD1 and Anti-CTLA4 Immunotherapy.

|May 12, 2026
Blinded by the Smoke: Are We Ignoring a Key Modifier of Response in Nonmuscle-Invasive Bladder Cancer Trials?

|Jan 09, 2026
Computational design of orthogonal TCR α/β interfaces for dual-TCR therapeutics.

Tomoaki Kinjo, Shawn Yu, Nathan Nicely

|Dec 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.

Michael S Sturdivant, Andrew S Truong, Mi Zhou

|Oct 01, 2024
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.

Xin Zhou, Ying Wang, Zhangqi Dou

|Aug 08, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.

N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi

Pageof 3

Frequent Collaborators

7 joint publications

Mi Zhou

6 joint publications

Jeffrey S Damrauer

5 joint publications

Matthew I Milowsky

3 joint publications

Benjamin G Vincent